Get Thee to the Market, Scientist

Dream inventions may fizzle. Managers and marketers can interfere with research and nudge scientists out of key decisions. Commercial product development is fraught with problems. But inventors in academia urge their colleagues to brave the risks and take their ideas to market anyway. At least that's the sentiment emerging from a reader survey conducted by The Scientist. "Do it," insists one respondent, even though a university developed a product based on her research without compensating, or

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

At least that's the sentiment emerging from a reader survey conducted by The Scientist. "Do it," insists one respondent, even though a university developed a product based on her research without compensating, or even consulting her.(The Scientistdoes not disclose the names of its survey participants.)

"Network!" says one scientist even though his product proposal was "not seriously considered" when he presented it to a relative in business, a venture capitalist, and a consulting firm. His advice? "Form a group of colleagues who can divide among them the many different tasks involved in commercial development."

Source: The Scientist reader survey, "Taking Science to the Market: A Survey of Academic-Private Sector Alliances."


Such enthusiastic endorsements reflect the views of participants in "Taking Science to the Market: A Survey of Academic-Private Sector Alliances" (www.the-scientist.com/yr2001/aug/results_010820.html). The unscientific Web-based survey was conducted by E-mailing invitations to 1,474 readers of The Scientist. More than half the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Paula Park

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours